Trevi Therapeutics, Inc. (TRVI)
NASDAQ: TRVI · Real-Time Price · USD
13.97
+0.13 (0.94%)
Apr 29, 2026, 11:57 AM EDT - Market open
Trevi Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 18.91 | 34.1 | 32.4 | 12.59 | 36.83 | Upgrade
|
| Short-Term Investments | 169.35 | 73.53 | 50.57 | 107.92 | - | Upgrade
|
| Cash & Short-Term Investments | 188.26 | 107.62 | 82.97 | 120.51 | 36.83 | Upgrade
|
| Cash Growth | 74.93% | 29.71% | -31.15% | 227.21% | -18.16% | Upgrade
|
| Other Receivables | 0.99 | 0.53 | 0.49 | - | - | Upgrade
|
| Receivables | 0.99 | 0.53 | 0.49 | - | - | Upgrade
|
| Prepaid Expenses | 1.26 | 0.94 | 3.62 | 0.8 | 0.89 | Upgrade
|
| Other Current Assets | 1.15 | 0.34 | 0.47 | 1.31 | 0.24 | Upgrade
|
| Total Current Assets | 191.66 | 109.43 | 87.55 | 122.62 | 37.96 | Upgrade
|
| Property, Plant & Equipment | 0.86 | 1.23 | 1.56 | 0.19 | 0.18 | Upgrade
|
| Other Long-Term Assets | 0.93 | 0.24 | 0.3 | 0.21 | 0.33 | Upgrade
|
| Total Assets | 193.44 | 110.9 | 89.4 | 123.02 | 38.48 | Upgrade
|
| Accounts Payable | 3.91 | 3.41 | 1.81 | 2.86 | 2.85 | Upgrade
|
| Accrued Expenses | 5.53 | 6.81 | 3.71 | 3.52 | 3.81 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | - | 7 | 5.95 | Upgrade
|
| Current Portion of Leases | 0.31 | 0.29 | 0.31 | 0.03 | 0.12 | Upgrade
|
| Total Current Liabilities | 9.75 | 10.51 | 5.82 | 13.4 | 12.72 | Upgrade
|
| Long-Term Debt | - | - | - | 2.15 | 8.65 | Upgrade
|
| Long-Term Leases | 0.45 | 0.75 | 1.03 | 0 | 0.02 | Upgrade
|
| Other Long-Term Liabilities | - | - | - | 0 | - | Upgrade
|
| Total Liabilities | 10.2 | 11.26 | 6.86 | 15.56 | 21.4 | Upgrade
|
| Common Stock | 0.13 | 0.09 | 0.07 | 0.06 | 0.03 | Upgrade
|
| Additional Paid-In Capital | 512.77 | 386.53 | 321.64 | 317.59 | 197.96 | Upgrade
|
| Retained Earnings | -329.8 | -287.05 | -239.13 | -210.07 | -180.92 | Upgrade
|
| Comprehensive Income & Other | 0.15 | 0.06 | -0.03 | -0.12 | - | Upgrade
|
| Total Common Equity | 183.24 | 99.64 | 82.55 | 107.46 | 17.08 | Upgrade
|
| Shareholders' Equity | 183.24 | 99.64 | 82.55 | 107.46 | 17.08 | Upgrade
|
| Total Liabilities & Equity | 193.44 | 110.9 | 89.4 | 123.02 | 38.48 | Upgrade
|
| Total Debt | 0.75 | 1.03 | 1.34 | 9.18 | 14.74 | Upgrade
|
| Net Cash (Debt) | 187.51 | 106.59 | 81.63 | 111.33 | 22.09 | Upgrade
|
| Net Cash Growth | 75.91% | 30.57% | -26.68% | 404.06% | -28.27% | Upgrade
|
| Net Cash Per Share | 1.39 | 1.05 | 0.82 | 1.72 | 0.97 | Upgrade
|
| Filing Date Shares Outstanding | 128.4 | 96.68 | 68.96 | 60.05 | 30.81 | Upgrade
|
| Total Common Shares Outstanding | 128.31 | 93.6 | 68.28 | 59.94 | 28.51 | Upgrade
|
| Working Capital | 181.91 | 98.92 | 81.72 | 109.22 | 25.23 | Upgrade
|
| Book Value Per Share | 1.43 | 1.06 | 1.21 | 1.79 | 0.60 | Upgrade
|
| Tangible Book Value | 183.24 | 99.64 | 82.55 | 107.46 | 17.08 | Upgrade
|
| Tangible Book Value Per Share | 1.43 | 1.06 | 1.21 | 1.79 | 0.60 | Upgrade
|
| Machinery | 0.51 | 0.35 | 0.3 | 0.21 | 0.11 | Upgrade
|
| Construction In Progress | 0 | 0.01 | 0.02 | 0.05 | - | Upgrade
|
| Leasehold Improvements | 0.03 | 0.03 | 0.03 | 0.13 | 0.13 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.